Next Article in Journal
A Neonate with Autosomal Dominant Pseudohypoaldosteronism Type 1 Due to a Novel Microdeletion of the NR3C2 Gene at 4q31.23
Next Article in Special Issue
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
Previous Article in Journal
Association of Blood Mercury Levels with the Risks of Overweight and High Waist-to-Height Ratio in Children and Adolescents: Data from the Korean National Health and Nutrition Examination Survey
Previous Article in Special Issue
The Evolution of the Role of Imaging in the Diagnosis of Craniosynostosis: A Narrative Review
 
 
Article
Peer-Review Record

Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

Children 2021, 8(12), 1089; https://doi.org/10.3390/children8121089
by Shang-An Hung 1,†, Chung-Lun Liao 2,†, Wei-Pin Lin 1, Jason C. Hsu 3, Yao-Hong Guo 1 and Yu-Ching Lin 1,4,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Children 2021, 8(12), 1089; https://doi.org/10.3390/children8121089
Submission received: 16 October 2021 / Revised: 6 November 2021 / Accepted: 15 November 2021 / Published: 25 November 2021
(This article belongs to the Special Issue Child Neurodisability)

Round 1

Reviewer 1 Report

Dear Editor,

thank you for the opportunity to review this interesting manuscript about the use of botulinum toxin in children with cerebral palsy with sialorrhea. 

The topic is relevant because it gives us a comprehensive review of botulinum toxin use in sialorrhea patients with cerebral palsy. The papar is well written and easy to read. The conclusions are consistent with the presented evidence and arguments and address to the posed main question.

Best regards.  

Author Response

Thank you very much for your review.

Reviewer 2 Report

congratulations to the authors for the well-written article. Please answer the following comments.

  1. There are only 4 articles eligible for the meta-analysis, which is a very limited number of articles to come to a conclusion about the efficiency of effectiveness, and safety of botulinum 19n toxin type A (BoNT-A) injection in cerebral palsy.
  2. can you please explain in detail the 3 types of BoNT-A?
  3. Does onabotulinumtoxinA FDA approve for treating sialorrhea in children with Cerebral palsy? is it an off-label use?
  4. Please comment about rimabotulinumtoxinB use in sialorrhea in CP children and is it FDA approved? Also please cite any article if available.
  5. The reference article 21 stated major complications in 5 patients who were hospitalized after BoNT-A injection. Can the authors explain how they came to a conclusion the use of BoNT-A is safe with very few side effects?

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 3 Report

I consider the article to be of great importance, it has been easy for me to read and it is well structured. The conclusions are related to the objectives and highlight the importance of the topic and the need to continue researching it to improve the scientific evidence. I have no extra considerations for authors 

Author Response

Thank you very much for your review

Round 2

Reviewer 2 Report

Thank you for the review

Back to TopTop